483 Document: AstraZeneca Pharmaceuticals, LP, Jan 19, 2023

FDANews 483 AstraZeneca Pharmaceuticals, LP Jan 19 2023 top
Sena G. Dissmeyer FDA Investigator Anastasia M. Shields FDA Investigator

On Jan 19, 2023, the FDA inspected AstraZeneca Pharmaceuticals, LP's Frederick site. Explore the inspectional observations.